IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LP

Q4 2025 Holdings

Filed 2026-02-17 | 24 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Liquidia Corporation(LQDA)COM NEW53635D202$280.0M8,118,89223.1%
Abivax SA(ABVX)SPONSORED ADS00370M103$195.8M1,451,92416.1%
Revolution Medicines Inc(RVMD)COM76155X100$102.3M1,283,9008.4%
Mineralys Therapeutics Inc(MLYS)COM603170101$100.6M2,772,6548.3%
Mineralys Therapeutics Inc(MLYS)PutCOM603170101$83.4M2,298,4006.9%
Vaxcyte Inc(PCVX)COM92243G108$78.7M1,704,8156.5%
Exelixis Inc(EXEL)COM30161Q104$68.1M1,553,2625.6%
Adma Biologics Inc(ADMA)COM000899104$54.9M3,012,5084.5%
Tango Therapeutics Inc(TNGX)COM87583X109$33.0M3,729,8952.7%
Inhibrx Biosciences Inc(INBX)COM45720N103$25.6M323,5652.1%
Tyra Biosciences Inc(TYRA)COM90240B106$24.8M944,2572.0%
Xenon Pharmaceuticals Inc(XENE)PutCOM98420N105$24.6M549,7002.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$24.6M549,6652.0%
Maze Therapeutics Inc(MAZE)COM578784100$22.8M550,1911.9%
Rapt Therapeutics Inc(RAPT)COM NEW75382E208$21.8M644,4001.8%
Avalo Therapeutics Inc(AVTX)COM NEW05338F306$16.0M881,5331.3%
Anika Therapeutics Inc(ANIK)COM035255108$13.8M1,435,1301.1%
Inhibrx Biosciences Inc(INBX)CallCOM45720N103$11.9M150,0001.0%
VOR Biopharma Inc(VOR)COM NEW929033207$10.0M925,0670.8%
Inventiva SA(IVA)ADS46124U107$9.3M2,000,0000.8%
Verrica Pharmaceuticals Inc(VRCA)COM SHS92511W207$7.7M923,9100.6%
Agios Pharmaceuticals Inc(AGIO)CallCOM00847X104$2.4M90,0000.2%
Spruce Biosciences Inc(SPRB)COM NEW85209E208$1.8M20,5140.1%
Eledon Pharmaceuticals Inc(ELDN)COM28617K101$839.5K555,9780.1%